Immune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancerPierre-Étienne Heudel, Jean-Luc Soubirou, Sylvie Chabaud et al.|ESMO Open|2021Cited by 35
Outcome of 1773 superficial non-dermatofibrosarcoma sarcomas A French Sarcoma Group study (FSG) from the NETSARC databaseEmmanuelle Bompas, Jean‐Yves Blay, M. Saint‐Jean et al.|European Journal of Cancer|2025Cited by 0